In the News: 11/04

Methotrexate: In Low Doses, No Harm To Bone Health Despite in vitro studies showing that methotrexate can bring on negative changes in bone mass, in low doses-from 7.5 to 20 milligrams a week-the popular arthritis drug poses no risk of osteoporosis. So concludes a recent Italian study that tested 731 female patients with rheumatoid arthritis who were divided on the basis of methotrexate use (non-users vs. patients who had taken the drug for at least six…
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access